Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: <i>In Vitro</i> and <i>In Vivo</i> Anti-Inflammatory Characterization-Reference-Cited by-同舟云学术

Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization

Published:2022-11-01 Issue:21 Volume:65 Page:14456-14480
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cerqua Ida¹,Musella Simona²,Peltner Lukas Klaus³,D’Avino Danilo¹^ORCID,Di Sarno Veronica²,Granato Elisabetta¹,Vestuto Vincenzo²,Di Matteo Rita¹,Pace Simona³,Ciaglia Tania²,Bilancia Rossella¹³,Smaldone Gerardina²,Di Matteo Francesca²,Di Micco Simone⁴^ORCID,Bifulco Giuseppe²^ORCID,Pepe Giacomo²^ORCID,Basilicata Manuela Giovanna²,Rodriquez Manuela²,Gomez-Monterrey Isabel M.¹^ORCID,Campiglia Pietro²⁴^ORCID,Ostacolo Carmine¹^ORCID,Roviezzo Fiorentina¹,Werz Oliver³^ORCID,Rossi Antonietta¹,Bertamino Alessia²^ORCID

Affiliation:

1. Department of Pharmacy, University Federico II of Naples, Via D. Montesano 49, 80131 Naples, Italy

2. Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, Salerno, Italy

3. Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University, Philosophenweg 14, D-07743 Jena, Germany

4. European Biomedical Research Institute (EBRIS), Via S. De Renzi 50, 84125 Salerno, Italy

Funder

Freistaat Th?ringen

Associazione Italiana per la Ricerca sul Cancro

Universit? degli Studi di Napoli Federico II

European Social Fund

Regione Campania

Publisher